Company press releases

Displaying 1 - 50 of 252 results
Released Company Title Industry Topic
08 Jul 2026
18:00 CEST 		OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Legal
06 Jul 2026
18:30 CEST 		OXURION Oxurion franchit une nouvelle étape dans le développement de sa plateforme Exagis avec le lancement commercial de son module eTMF 20103010 Biotechnology Legal
06 Jul 2026
18:30 CEST 		OXURION Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module 20103010 Biotechnology Legal
26 Jun 2026
18:00 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Legal
24 Jun 2026
18:00 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Legal
19 Jun 2026
15:45 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Legal
15 Jun 2026
19:30 CEST 		OXURION Major market validation: Pierre Fabre Laboratories uses Oxurion's Exagis Platform 20103010 Biotechnology Legal
15 Jun 2026
19:30 CEST 		OXURION Validation majeure du marché : les Laboratoires Pierre Fabre utilisent la plateforme Exagis d'Oxurion 20103010 Biotechnology Legal
10 Jun 2026
18:00 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
10 Jun 2026
18:00 CEST 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
08 Jun 2026
21:00 CEST 		OXURION Oxurion lance une stratégie de croissance axée sur le logiciel avec Exagis 20103010 Biotechnology Legal
08 Jun 2026
21:00 CEST 		OXURION Oxurion launches a software-driven growth strategy with Exagis 20103010 Biotechnology Legal
03 Jun 2026
18:00 CEST 		OXURION Oxurion kondigt resultaten aan van de Jaarlijkse Aandeelhoudersvergadering van 1 juni 2026 20103010 Biotechnology General meeting / Board Meeting, Meetings / events
03 Jun 2026
18:00 CEST 		OXURION Oxurion Announces Results on the Annual Shareholders' Meeting of 1 June 2026 20103010 Biotechnology General meeting / Board Meeting, Meetings / events
02 Jun 2026
18:00 CEST 		OXURION Oxurion expands its capabilities to address the growing demand for GLP-1 and peptide clinical research services 20103010 Biotechnology Legal
02 Jun 2026
18:00 CEST 		OXURION Oxurion étend ses compétences pour répondre à la demande croissante de services de recherche clinique dédiés aux GLP-1 et aux peptides 20103010 Biotechnology Legal
02 Jun 2026
08:00 CEST 		OXURION Oxurion - Termination of discussions for the French CRO project (LOI dated 13/10/25) and prioritization of the international target (LOI dated 19/03/26) 20103010 Biotechnology Legal
02 Jun 2026
08:00 CEST 		OXURION Oxurion - arrêt du projet de CRO française (LOI du 13/10/25) et priorité à la cible internationale (LOI du 19/03/26) 20103010 Biotechnology Legal
29 May 2026
18:00 CEST 		OXURION Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
29 May 2026
18:00 CEST 		OXURION Oxurion ontvangt transparantiekennisgevingen van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
27 May 2026
18:00 CEST 		OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
27 May 2026
18:00 CEST 		OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
26 May 2026
18:00 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
26 May 2026
18:00 CEST 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
05 May 2026
18:00 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
05 May 2026
18:00 CEST 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
30 Apr 2026
18:30 CEST 		OXURION Publication Annual Report - Annual Shareholders Meeting 20103010 Biotechnology General meeting / Board Meeting, Meetings / events
30 Apr 2026
18:30 CEST 		OXURION Publicatie jaarverslag Jaarlijkse Algemene Vergadering 20103010 Biotechnology General meeting / Board Meeting, Meetings / events
16 Apr 2026
18:00 CEST 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
16 Apr 2026
18:00 CEST 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
07 Apr 2026
18:00 CEST 		OXURION Postponement Annual Shareholders Meeting 20103010 Biotechnology General meeting / Board Meeting, Meetings / events
07 Apr 2026
18:00 CEST 		OXURION Uitstel Gewone Algemene Vergadering 20103010 Biotechnology General meeting / Board Meeting, Meetings / events
19 Mar 2026
18:30 CET 		OXURION Oxurion signe une lettre d'intention pour l'acquisition d'une CRO internationale 20103010 Biotechnology Legal
19 Mar 2026
18:30 CET 		OXURION Oxurion signs a letter of intent for the acquisition of an international CRO 20103010 Biotechnology Legal
18 Mar 2026
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
18 Mar 2026
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
16 Mar 2026
18:00 CET 		OXURION Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas 20103010 Biotechnology Change in Capital
16 Mar 2026
18:00 CET 		OXURION Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie 20103010 Biotechnology Change in Capital
10 Mar 2026
18:30 CET 		OXURION Oxurion prolonge son programme de financement 20103010 Biotechnology Legal
10 Mar 2026
18:30 CET 		OXURION Oxurion Extends Its Financing Program 20103010 Biotechnology Legal
27 Feb 2026
18:00 CET 		OXURION Oxurion confirms continuation of discussions regarding its proposed acquisition of a French CRO 20103010 Biotechnology Legal
27 Feb 2026
18:00 CET 		OXURION Oxurion confirme la poursuite des discussions sur son projet d'acquisition d'une CRO française 20103010 Biotechnology Legal
25 Feb 2026
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
25 Feb 2026
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
19 Feb 2026
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
19 Feb 2026
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
16 Feb 2026
08:00 CET 		OXURION Axiodis CRO accelerates its sales and marketing strategy to support ambitious growth driven by Oxurion 20103010 Biotechnology Legal
16 Feb 2026
08:00 CET 		OXURION Axiodis CRO accélère sa stratégie commerciale et marketing pour soutenir une croissance ambitieuse sous l'impulsion d'Oxurion 20103010 Biotechnology Legal
26 Jan 2026
18:00 CET 		OXURION Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital
26 Jan 2026
18:00 CET 		OXURION Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC 20103010 Biotechnology Change in Capital